In vitro activities of 10 antifungal drugs against 508 dermatophyte strains
about
Analysis of the dermatophyte Trichophyton rubrum expressed sequence tags.Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum.Trichophyton tonsurans strains from Brazil: phenotypic heterogeneity, genetic homology, and detection of virulence genes.Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.Review of the safety and efficacy of voriconazole.Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.Sertaconazole nitrate shows fungicidal and fungistatic activities against Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, causative agents of tinea pedis.In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients.Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrumPreparation and evaluation of dermal delivery system of griseofulvin containing vitamin E-TPGS as penetration enhancerEmerging azole antifungals.In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis.A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation.Efficacy of albaconazole against Candida albicans in a vaginitis model.Anti dermatophytic therapy--prospects for the discovery of new drugs from natural products.Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran.In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method.In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods.Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits.A randomized, double-blind, multiple-dose, placebo-controlled, dose escalation study with a 3-cohort parallel group design to investigate the tolerability and pharmacokinetics of albaconazole in healthy subjects.Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay.In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes.Topical and systemic antifungals in dermatology practice.In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.Investigation of In Vitro Activity of Five Antifungal Drugs against Dermatophytes Species Isolated from Clinical Samples Using the E-Test Method.Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes.In Vitro Antifungal Susceptibility Profiles of 12 Antifungal Drugs against 55 Trichophyton schoenleinii Isolates from Tinea Capitis Favosa Patients in Iran, Turkey, and ChinaIn-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran.In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.Synergistic inhibition of the growth in vitro of Microsporum canis by miconazole and chlorhexidine.Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp.In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
P2860
Q33259999-237E7CAF-5CE5-43A6-AD6A-C711368024CEQ33261315-0774F950-0CBA-4FE0-9A77-7B7F54C282F7Q34383674-0BE37F25-5360-4AAD-B548-830A53723637Q34437623-7C5EACFD-FB02-4978-87A0-1ACFE98D7BCFQ34544679-DE74FFA2-BC1F-4A90-91EE-0A7FCE6F389DQ35072285-EFB3780D-65B0-44DE-B0F5-D3BF5AA5199EQ35103898-E2C5874D-4477-4A8C-AFFA-833B5A96101DQ35191523-B9E52A1E-F24E-46F0-B0AB-3D56C2832A1DQ35506255-7F8DF281-8CC8-4BF2-A321-CC65C1E6474FQ35746245-68B56E7F-A8B0-4B92-9991-C367C70BECC5Q35821835-16CB9CF7-6F44-44AD-9FBB-FF863A4E1D1EQ36066009-E65A4D5A-1FD0-41F7-AB03-06D79A2C0909Q36094896-66CFC698-BC03-4BCD-9236-D7E819173A91Q36587695-85E40030-2D89-4FA7-99FE-C45C4B59FDCDQ37392798-7321D192-2382-41EE-AC06-6C5292511E15Q38201012-7F946253-2F1B-448E-8E57-57464C123B4CQ38876515-6DB63296-7B4E-45CA-B496-DE0DD1321F7EQ38878593-B9A60527-9206-4054-BB22-B99F696FF6FDQ38887854-9EAE4CFE-F8A3-433A-9A7A-D2259BD58BBEQ39274300-F139EAAA-5C4A-4DE2-AEFF-3F1DBB00C45DQ39755529-7C9268A4-039A-42CC-BCB5-9FF723051BF7Q39810673-CEF002B7-009A-417F-AF70-77B8079154DFQ40133135-E3803F8A-23CC-435F-B8BC-728AEB4DE313Q40173073-733D11F6-8169-41FE-8957-B7F93BD02CB8Q40442939-3A078CAA-91F1-47F3-90BB-202FAF51AE47Q40968174-2987230E-4246-4D9F-A753-25215216089AQ41440263-A67A4814-81F2-4E1C-ABB5-8A99271835C3Q41528900-162F18FD-36D2-46F8-975B-FA34808FBB2FQ41869129-29D96B5F-CBA0-46DC-8F37-EFEC7AA9595BQ42108568-37C09205-8019-43EF-930C-529DBDFA95ABQ42927428-2A6829D7-4AC6-4E54-BD4A-5C3C267F5740Q43532827-64341FB4-08E3-41ED-8F86-D443D90E96D7Q43716683-96F807AE-FC48-474C-BB19-7DC9E99C9242Q44380486-B9689923-67CA-4AAC-999E-212DD9F1DDC1Q44536267-00237CF7-D962-4039-8E5F-602E63697741Q44657018-93CC3BBC-F8CD-4838-B611-E4CCC9186DD7Q45002264-87FFECCC-B759-4320-B1FB-B89820C03064Q46439302-363CB988-F41D-4ECC-A342-7FDECDFDD097Q46447096-078BB179-0E98-4DB7-9D83-1F4C5AD757D4Q46448469-62F87915-B3EC-4CD4-913A-C2DB65F5225D
P2860
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains
@en
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains.
@nl
type
label
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains
@en
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains.
@nl
prefLabel
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains
@en
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains.
@nl
P2093
P2860
P1476
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains
@en
P2093
A Del Palacio
A J Carrillo
A Valverde
B Fernández-Torres
P2860
P304
P356
10.1128/AAC.45.9.2524-2528.2001
P407
P50
P577
2001-09-01T00:00:00Z